Expression System for Isolation of Membrane Associated Protein

Information

  • Research Project
  • 7404781
  • ApplicationId
    7404781
  • Core Project Number
    R43GM083413
  • Full Project Number
    1R43GM083413-01
  • Serial Number
    83413
  • FOA Number
    PA-07-80
  • Sub Project Id
  • Project Start Date
    2/1/2008 - 16 years ago
  • Project End Date
    7/31/2008 - 15 years ago
  • Program Officer Name
    EDMONDS, CHARLES G.
  • Budget Start Date
    2/1/2008 - 16 years ago
  • Budget End Date
    7/31/2008 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
  • Award Notice Date
    1/21/2008 - 16 years ago

Expression System for Isolation of Membrane Associated Protein

[unreadable] DESCRIPTION (provided by applicant): The characterization of integral membrane proteins is limited most by the inability to isolate such proteins in sufficient quantities. The isolation of eukaryotic membrane proteins is especially problematic. We propose to address this issue by developing a portfolio of tools for the reliable expression, detection, and purification of integral membrane proteins. In phase I, specialized E. coli host strains and expression vectors will be constructed to enable efficient targeting of heterologous proteins to the inner membrane of E. coli. Our recent research efforts have identified promising N-terminal partner peptides for targeting and membrane accumulation of model E. coli proteins. In phase I, we plan to evaluate these protein fusion strategies for the over-production and functional membrane assembly of a eukaryotic membrane protein. Host strains will carry a Cpx reporter allele (see definitions) so that the Cpx envelope stress response of E. coli may be monitored in order to optimize expression and membrane assembly of the protein of interest. We also propose to demonstrate proof-of- principle for a high-throughput whole-cell ELISA method for assessing membrane accumulation of fusion proteins of interest. [unreadable] [unreadable] Phase II research will focus on validating the expression system for the over-production and isolation of eukaryotic membrane receptors. The expression trials will include a thorough investigation of the advantages of the host Cpx stress reporter system. In addition, the whole- cell ELISA method will be employed to assess expression and proper targeting of heterologous membrane proteins. High-throughput ELISA analysis of membrane assembly will be correlated to results obtained via a conventional cell fractionation and immunoblot procedure. Strain improvements (i.e. deletion of cell envelope proteases) will be evaluated by measuring yield of full-length membrane receptor. Phase II will also include development of improved protein isolation methods. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    107000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:107000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NEW ENGLAND BIOLABS, INC.
  • Organization Department
  • Organization DUNS
    066605403
  • Organization City
    IPSWICH
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01938
  • Organization District
    UNITED STATES